Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › YATHARTH

YATHARTH

Yatharth Hospital & Trauma Care Services Limited
Micro-capHealthcare ↗

What the six lenses say about YATHARTH — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹994.8
2026-09-08
VWAP · 1Y anchor
₹757
+31.5% from VWAP
P/E · TTM
54.4×
TTM EPS ₹18.3
52-week range
98%
position low→high
RSI(14)
70
momentum

Own sector index

Healthcare ↗
Neutral

1M

-1.1%

3M

+7.1%

1Y

+14.5%

Breadth >EMA21

55%

How YATHARTH’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
5.0
avg conviction decile
Leadership
—
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Micro-cap cohortDRaw
TechnicalD890›

The actual numbers

Price vs VWAP (1y)+31.5%
EMA trend stackUp · 21>50>200
Price vs 200-EMA+27.2%
Price vs 50-EMA+12.4%
RSI(14)70
RS vs Nifty 500 · 3M+17.3%
RS vs sector · 3M+14.6%
52-week range98%
Volume vs 30d avg0.62×
Volume vs 60d avg0.77×
ATR(14) · volatility39.6
Bollinger width · vol contraction0.260
FundamentalD968›

The actual numbers

Return on equity (ROE)9.6%
Operating margin19.1%
Net margin14.3%
Revenue growth · YoY+36.1%
EPS growth · YoY+24.2%
Debt / equity0.15×

Full 8-quarter history in the financials table below.

ValuationD312›

The actual numbers

P/E (TTM)54.4×
TTM EPS₹18.3
52-week range98%
CatalystD638›

The actual numbers

Earnings & momentum35
Capital actions13
Governance98

Every filing in the corporate-announcements panel below.

FlowD242›

The actual numbers

Promoter holding55.8%
Delivery · 30d avg47.6%
Up/down-day asymmetry-4.8pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D8 + D2 ) ÷ 2 = 5.0(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Highest
85
Conviction score 85/100 · avg-decile strength 5.0/10
Conviction score85/100›
TechnicalD8›
FundamentalD9›
ValuationD3›
CatalystD6›
FlowD2›

Policy

Government policy · Healthcare

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+0.9pp
+0.5pp
+17.6pp
+18.9pp
+56.4pp
+30.4pp
Nifty 500
Broad-market baseline
+0.8pp
+0.5pp
+16.6pp
+17.3pp
+50.7pp
+25.2pp
Sector
Own-sector index
—
—
+15.2pp
+14.6pp
+42.0pp
+11.9pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

YATHARTH daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
994.80+3.70

Relative strength

RS vs baseline · rebased to 100

YATHARTH ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
197.30+1.56

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)212218219232258279320342
↳ change QoQ—+2.8%+0.6%+5.9%+11.2%+8.1%+14.7%+6.9%
EBITDA (₹cr)5758595764657480
EBITDA margin27.1%26.5%27.0%24.6%24.8%23.3%23.1%23.4%
PAT (₹cr)3031303942414345
↳ change QoQ—+1.9%-1.5%+27.9%+7.7%-2.4%+4.9%+4.7%
Net margin14.3%14.2%13.9%16.8%16.3%14.7%13.4%13.2%
EPS (₹)3.543.593.574.024.364.284.714.93
D/E————————
YoY growth · Mar '26Revenue +47.4% YoYPAT +15.4% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 3 Sep '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 28 Aug '26
    LOWgovernance
    News Verification
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 28 Aug '26
    LOWgovernance
    News Verification
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 21 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 18 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 Aug '26
    LOWgovernance
    Monitoring Agency Report
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 11 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 11 Aug '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 10 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 10 Aug '26
    LOWgovernance
    Options to purchase securities
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 10 Aug '26
    MEDIUMcapital
    Dividend
    ›

    A dividend declaration — a cash return to shareholders.

    View original filing on NSE ↗
  • 10 Aug '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 10 Aug '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 10 Aug '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 10 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds YATHARTH

Mutual funds holding YATHARTH (7)

FundWeightAUM ₹crGrade
Bandhan Small Cap Reg Gr1.07%31,103
Kotak Multicap Reg Gr0.88%29,274
Kotak Balanced Advantage Fund Reg Gr0.52%17,429
Groww Multicap Reg Gr1.82%924
Kotak Healthcare Reg Gr2.99%682
Groww Small Cap Reg Gr2.19%573
Samco Multi Cap Reg Gr0.54%228

ETFs holding YATHARTH (1)

ETFWeightGrade
Groww BSE Hospitals ETF1.41%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Healthcare